MENU
LFSC
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

LFSC stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

Category: #Health
LFSC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for LFSC with price predictions
Jul 13, 2026

Momentum Indicator for LFSC turns positive, indicating new upward trend

LFSC saw its Momentum Indicator move above the 0 level on June 11, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator turned positive. In of the 24 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for LFSC just turned positive on June 11, 2026. Looking at past instances where LFSC's MACD turned positive, the stock continued to rise in of 14 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LFSC advanced for three days, in of 92 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 88 cases where LFSC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for LFSC moved out of overbought territory on July 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 20 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Guardant Health (NASDAQ:GH), Sarepta Therapeutics (NASDAQ:SRPT).

Industry description

The investment seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund’s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

Market Cap

The average market capitalization across the F/m Emerald Life Sciences Innovation ETF ETF is 6.51B. The market cap for tickers in the group ranges from 476.57M to 23.66B. INSM holds the highest valuation in this group at 23.66B. The lowest valued company is OFIX at 476.57M.

High and low price notable news

The average weekly price growth across all stocks in the F/m Emerald Life Sciences Innovation ETF ETF was -0%. For the same ETF, the average monthly price growth was 15%, and the average quarterly price growth was 28%. BBIO experienced the highest price growth at 7%, while RDNT experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the F/m Emerald Life Sciences Innovation ETF ETF was -9%. For the same stocks of the ETF, the average monthly volume growth was -40% and the average quarterly volume growth was -55%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 70
P/E Growth Rating: 74
Price Growth Rating: 47
SMR Rating: 83
Profit Risk Rating: 79
Seasonality Score: 16 (-100 ... +100)
View a ticker or compare two or three
LFSC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Momentum Indicator for LFSC turns positive, indicating new upward trend